Associated factors for the development of acute coronary syndrome or stable coronary artery disease-Reference-Cited by-同舟云学术

Associated factors for the development of acute coronary syndrome or stable coronary artery disease

Published:2016 Issue:3 Volume:22 Page:139-144
ISSN:1341-7703
Container-title:Journal of the Japanese Coronary Association
language:en
Short-container-title:J Jpn Coron Assoc

Author:

Sasaki Osamu¹,Nishioka Toshihiko¹,Inokuchi Takafumi¹,Takatori Hirotaka¹,Nakata Takaaki¹,Nakamura Yoshihiro¹,Nakato Takeshi¹,Tsukada Shun-ichi¹,Yamaguchi Ryutaro¹,Isshiki Ami¹,Toyama Kentaro¹,Ando Toshiyuki¹,Inoue Yoshiro¹,Kamiyama Tetsuo¹,Kirimura Masato¹,Ito Hiroyuki¹,Yoshimoto Nobuo¹,Sasaki Hideki²

Affiliation:

1. Division of Cardiology, Saitama Medical Center, Saitama Medical University

2. Department of Cardiovascular Surgery, Ehime Prefectural Central Hospital

Publisher

The Japanese Coronary Association

Link

https://www.jstage.jst.go.jp/article/jcoron/22/3/22_22.16-00006/_pdf

Reference32 articles.

1. 1) Pedersen TR, Kjekshus J, Berg K, et al: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389

2. 2) Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-1357

3. 3) Downs JR, Clearfield M, Weis S, et al: Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. AirForce/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279: 1615-1622

4. 4) Sacks FM, Pfeffer MA, Moye LA, et al: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators. N Engl J Med 1996; 335: 1001-1009

5. 5) Shepherd J, Cobbe SM, Ford I, et al: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-1307